Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Delta 9 Cannabis Inc DLTNF

Delta 9 Cannabis Inc. is a Canada-based vertically integrated cannabis company. The Company operates through three segments: Wholesale Cannabis, Retail Cannabis and Merchandise and Devices, and Business to Business. The Company sells cannabis products through its wholesale and retail sales channels and sells its cannabis growing pods to other businesses. Its cannabis products include dried cannabis and pre-rolled joints. Its edibles and vapes include vape pens and concentrates, edibles, and drinkables. The Company, through its wholly owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis products and operates a 95,000-square-foot Health Canada licensed production facility in Winnipeg, Manitoba, Canada. It also owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. It is focused on producing and selling cannabis oils, extracts, and derivative products.


GREY:DLTNF - Post by User

Bullboard Posts
Post by gnote1on Nov 11, 2020 5:17pm
408 Views
Post# 31880699

Financials out

Financials outLoss of 215000+  Here's a bit of the release.

  • Net revenue of $13.1 million for the third quarter of 2020, an increase of 97%, from $6.7 million for the same quarter last year.
    • Net revenue of $37.9 million for the first nine months of 2020, an increase of 79%, from $21.2 million for the same period last year.
  • Gross profit of $3.96 million for the third quarter of 2020, an increase of 95%, from $2.03 million for the same quarter last year.
    • Gross profit of $13.5 million for the first nine months of 2020, an increase of 98%, from $6.8 million for the same period last year.
  • Net income (loss) from operations and Adjusted EBITDA (loss) was $(5.5) million and $(0.5) million respectively for the third quarter of 2020, largely a result of an unrealized loss on the fair value of biological assets in inventory, a non-cash item.
    • Net income (loss) from operations and Adjusted EBITDA for the first nine months of 2020 was a loss of $(0.4) million and gain of $1.9 million respectively.
  • The Company reported a strong financial position, with $7.2 million in cash, $25.6 million in working capital and total assets of $77.5 million.
Bullboard Posts